Kilitch Drugs (India) (KILITCH) — Board Meeting

📢 Key Event
34th AGM approved FY2026 financials and reappointed Mukund Mehta as director.

🔄 What Changed
Approved audited standalone and consolidated financial statements for FY2026; reappointed Mukund Mehta as director.

💡 Investor Takeaway
Shareholders approved key financials and leadership continuity, signaling stability but no immediate growth catalyst.

Kilitch Drugs held its 34th AGM on 27 August 2026 via video conference, approving audited financial statements for FY2026, reappointing Mukund Mehta as director, and authorizing performance-linked pay for executives. Shareholders participated electronically without proxy voting. The meeting concluded at 9:51 a.m. after 15 minutes of e-voting.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KILITCH ✨ Ask AI About This

About Kilitch Drugs (India) Ltd (KILITCH)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹599.24 Cr P/E: 13.7 ROE: 10.4% ROCE: 11.9%

View full KILITCH stock details →

📡 Get AI alerts when KILITCH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KILITCH — Free

💡 Ask AI about this filing

"How did FY2026 financials perform versus prior year?" "What is the expected impact of PLI on profitability?" "When will voting results be publicly disclosed?"

Ask AI Free →

📊 More KILITCH filings

See all KILITCH filings →

🔥 Also filed on 27 August 2026

JNPR Juniper Green Energy Ltd Financial Results AWFIS AWFIS Space Solutions Ltd Annual Report 509084 Photon Capital Advisors Ltd Annual Report GUJALKALI Gujarat Alkalies & Chemicals Ltd Annual Report EPACK Epack Durable Ltd Annual Report 538546 Bansal Roofing Products Ltd Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KILITCH files new disclosures

Track KILITCH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track KILITCH — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd